Brighter Initiates Commercial Partnership with DiapointME in the United Arab Emirates

Report this content

Brighter AB [publ], today announced that the company has initiated a commercial partnership with DiapointME, a diabetes-oriented digital platform and e-commerce site in the UAE. DiapointME is owned by Pamela Durant, a well-known regional profile in the diabetes community. The partnership entails that Brighter's pioneering product portfolio for diabetes, Actiste® and Actiste Mini® will be marketed and sold on the DiapointME platform, provided that all necessary data storage and telecommunications related product and market preparations are completed. 

“Pamela Durant is a very committed and well-known diabetes profile in the region with whom we have built a relationship over the past year. DiapointME cares deeply about improving the lives of people with diabetes and this is an exciting new sales channel in the UAE. I am very glad to initiate this partnership,” says Christer Trägårdh, interim CEO at Brighter.

"At DiapointME, we are very happy to be a part of Brighter's journey in the UAE and GCC. I look forward to collaborating with them as we support people with diabetes," says Pamela Durant, Founder and Managing Director at Diapoint.

DiapointME provides diabetes education, diabetes services, a diabetes network, advocacy and products to support people living with diabetes.

For further information, please contact:

Brighter Investor Relations

Certified Adviser

Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10,

About Brighter AB (publ)

Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.